Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.
about
Epigenetic principles and mechanisms underlying nervous system functions in health and diseaseNanoparticles: Alternatives Against Drug-Resistant Pathogenic MicrobesQuantum dots as a platform for nanoparticle drug delivery vehicle designRNAi-mediated gene silencing in tick synganglia: a proof of concept studyPreclinical and clinical development of siRNA-based therapeuticsOxidative Stress and Nano-Toxicity Induced by TiO2 and ZnO on WAG Cell LineAntibody-based imaging of HER-2: moving into the clinic.FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERYIn vivo imaging of RNA interference.Optical imaging-guided cancer therapy with fluorescent nanoparticlesLabile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexesNon-viral nanocarriers for siRNA delivery in breast cancer.Targeted delivery of siRNA into breast cancer cells via phage fusion proteins.Application of quantum dots as vectors in targeted survivin gene siRNA delivery.Current advances in polymer-based nanotheranostics for cancer treatment and diagnosisGold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus.Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.Designing multifunctional quantum dots for bioimaging, detection, and drug deliveryNanotechnology-based drug delivery systemsRecent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profilingImaging GABAc receptors with ligand-conjugated quantum dots.Theranostic agents for intracellular gene delivery with spatiotemporal imagingClinical potential of quantum dotsBioconjugated quantum dots for in vivo molecular and cellular imaging.Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives.Assessment of the evolution of cancer treatment therapiesMechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.Inorganic nanoparticles for predictive oncology of breast cancer.Multifunctional Quantum Dots for Personalized Medicine.Targeting the human serotonin transporter (hSERT) with quantum dots.Applications for site-directed molecular imaging agents coupled with drug delivery potential.Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery.Nanomaterial standards for efficacy and toxicity assessment.Engineering RNA for targeted siRNA delivery and medical application.Quantum dot-based theranostics.RNA interference in the clinic: challenges and future directions.Nanomaterials for regenerative medicine.Engineering Nanocarriers for siRNA Delivery.Fluorescent nanoparticle probes for imaging of cancer.A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS).
P2860
Q24657549-40636F79-C355-419A-B235-98444699E3B4Q26746108-9BD94BA8-9ECB-43E2-8ADE-D594B891B1D8Q26996556-8E1C0196-21AF-4CFE-BC57-B557E39E06B4Q27486085-0CFC2092-217D-4569-83E7-03E708528635Q28085290-58DE1211-0E38-42ED-B13B-9AAAE27B514CQ28394843-8E7BEDF1-E7F6-408C-B9C1-1816548EABDEQ30423880-6360A69E-450F-47B0-A83F-DBC6A89EDBBBQ30472645-1BA42D2F-5AAF-477C-9603-01C4B289D20DQ33348480-006AF58C-08AA-4F45-A5A6-CECB1D9F45AAQ33731037-AABA7B33-F6B6-4BF8-98BE-1A97A3290FC9Q34058107-B8DFBC1E-A5D7-40C7-A243-921B7568504BQ34079608-F6139FBC-2417-4758-8725-486838900C1BQ34501858-F2FB9C33-C040-4337-9069-4B0977E77B20Q34669968-BC41D160-966A-48BC-BBF6-ECA44EA7EE61Q34783018-F4FA9BFE-B333-4F10-8B0F-D1BD59B814CBQ35093276-DABEF2F8-1924-4714-8E70-C39186AEDB59Q35205410-F0FA2215-751C-48F9-A5D5-5D547506D717Q35538371-D1D86CFF-6506-467C-AA87-B4D6AADBCBF7Q36419770-CC057D38-21F7-413F-B4D4-89E54862E4B4Q36538483-F78B3C66-D2FC-466D-8C4B-B0EE1745603BQ36571299-DCFEAA8F-8843-42D8-8B6F-1D09B540CCC8Q36768805-A9A3AFA2-CBB3-47A0-AA5E-4D42154D142AQ37101245-4C0B2DA7-DFD1-48EF-81E8-39C633C321A9Q37113825-E8D7641E-F40E-471B-88D1-36E950D0962CQ37130501-5E38C441-1C44-48A8-9DEC-91856ABC6916Q37137408-6DD98216-D6A8-4A3D-A7F7-1A65C7B7F173Q37193000-5B8FF8FD-71B6-4774-8B39-301AE6BCB1FEQ37354229-52B26F39-188E-478B-A3D5-6ED71D2E137DQ37377137-B1FCE700-9EF2-464E-B8CB-1A7407B1297AQ37425189-F3E44181-8627-42A3-8021-B56F0DE7C4E5Q37529871-87353333-28E8-4B5E-BE0B-20CB200FE4B3Q37582396-5F6EFDFF-D7BA-4E5E-95BD-197176586037Q37668451-874BC70F-C852-4143-8B3F-6FF5CFAD93A8Q37709610-3CEECCB5-73F4-43CD-9C16-90200BEB9A7CQ37774587-8C85D3A1-B4E2-480F-90FF-C912219A78E1Q37821230-81822043-68FD-4C4A-A24E-F1995EC8D61AQ37823603-F8818652-842C-4117-9684-E8C79C96B2A0Q37849727-4BAE3848-D3D3-4C17-8334-F9568AA6D1D7Q37863663-785B4BAE-2A99-4167-9EBC-5331C3A22C6BQ37877661-35202682-8F0D-4153-9B5B-23AE8E173AC6
P2860
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Quantum-dot based nanoparticle ...... neu gene via RNA interference.
@en
type
label
Quantum-dot based nanoparticle ...... neu gene via RNA interference.
@en
prefLabel
Quantum-dot based nanoparticle ...... neu gene via RNA interference.
@en
P2093
P921
P1433
P1476
Quantum-dot based nanoparticle ...... neu gene via RNA interference.
@en
P2093
Shan Jiang
Wee Beng Tan
Yong Zhang
P304
P356
10.1016/J.BIOMATERIALS.2006.11.018
P577
2006-12-11T00:00:00Z